19 102 patients, 51 countries, 1139 centers Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R. Rationale, design, and baseline characteristics of.
SIGNIFY TRIAL
Results
Regression of atherosclerosis and related CV diseases
A step further in the management of stable coronary patients with ivabradine.
Pierluigi Tricoci, Denise M. D’Andrea, Paul A. Gurbel, Marina Cuchel, Brion M. Winston, Robert Schott, Robert J. Weiss, Henry E. Paez, Michael A. Blazing,
The SIGNIFY study
Results Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R. N Eng J Med. 2014 August 31. DOI:10.1056/NEJMoa1406430.
Tricoci P, N Engl J Med 2012 Farb A, Circulation 2003
Numero 2 de la Revista GEECVSEN
